McBride Discusses Theme for His Term as ACCC President
Ali McBride, PharmD, MS, BCOP, discusses the theme for his presidency: Collaborate. Educate. Compensate: A Prescription for Sustainable Cancer Care Delivery.<br />
Ali McBride, PharmD, MS, BCOP, Association of Community Cancer Centers (ACCC) President and clinical coordinator of hematology/oncology at The University of Arizona Cancer Center, discusses the theme for his presidency: Collaborate. Educate. Compensate: A Prescription for Sustainable Cancer Care Delivery.
Compensation is the foundation of what he would like to address during his term, says McBride. He plans to develop layers of understanding of the cost of care for patients, which is often overlooked. ACCC will provide further support and understanding on these measures.
The second piece of this theme is innovation, an ongoing strategic goal across both cancer care and healthcare in general. ACCC will provide more educational resources in understanding new models, new techniques, and new electronic devices, McBride says.
Fedratinib Shows Promise in Chronic Neutrophilic Leukemia and MDS/MPN
January 20th 2025In an interview, Andrew Kuykendall, MD, discussed fedratinib’s potential as an effective option for patients with myelodysplastic syndrome/myeloproliferative neoplasms and chronic neutrophilic leukemia.
Read More
Enasidenib Shows Promise as Post-Transplant Maintenance in IDH2-Mutated AML
January 7th 2025Amandeep Salhotra, MD, discussed the background and findings from a pilot trial evaluating enasidenib as post-hematopoietic stem cell transplant maintenance therapy for IDH2-mutated acute myeloid leukemia treatment.
Read More
Could Triapine With Lutetium 177 Dotatate Improve Outcomes for Neuroendocrine Tumors?
December 30th 2024Aman Chauhan, MD, highlights an ongoing phase 2 trial exploring the combination of triapine, a radiation sensitizer, with lutetium 177 dotatate for treating well-differentiated somatostatin receptor–-positive neuroendocrine tumors.
Read More
